VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,364,000 | -47.6% | 209,062 | -27.3% | 0.00% | -50.0% |
| Q4 2021 | $4,509,000 | +0.6% | 287,391 | +9.9% | 0.00% | -33.3% |
| Q3 2021 | $4,481,000 | -21.7% | 261,454 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $5,726,000 | +49.2% | 266,191 | +4.2% | 0.00% | +50.0% |
| Q1 2021 | $3,837,000 | +62.6% | 255,447 | +42.2% | 0.00% | +100.0% |
| Q4 2020 | $2,360,000 | +168.8% | 179,609 | +97.6% | 0.00% | 0.0% |
| Q3 2020 | $878,000 | -22.1% | 90,886 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $1,127,000 | +64.8% | 98,478 | +49.2% | 0.00% | 0.0% |
| Q1 2020 | $684,000 | -75.7% | 66,001 | -61.6% | 0.00% | -50.0% |
| Q4 2019 | $2,817,000 | +73.9% | 171,667 | +40.7% | 0.00% | +100.0% |
| Q3 2019 | $1,620,000 | +29.3% | 121,991 | +37.2% | 0.00% | 0.0% |
| Q2 2019 | $1,253,000 | +12.1% | 88,914 | +46.3% | 0.00% | 0.0% |
| Q1 2019 | $1,118,000 | -65.4% | 60,779 | -50.9% | 0.00% | -66.7% |
| Q4 2018 | $3,233,000 | +531.4% | 123,721 | +455.1% | 0.00% | – |
| Q3 2018 | $512,000 | +52.4% | 22,290 | +26.5% | 0.00% | – |
| Q2 2018 | $336,000 | -39.0% | 17,619 | -51.4% | 0.00% | -100.0% |
| Q4 2017 | $551,000 | -53.1% | 36,241 | -44.7% | 0.00% | 0.0% |
| Q3 2017 | $1,174,000 | +95.0% | 65,576 | +77.6% | 0.00% | 0.0% |
| Q2 2017 | $602,000 | +78.1% | 36,919 | +52.9% | 0.00% | 0.0% |
| Q1 2017 | $338,000 | -17.4% | 24,150 | -5.8% | 0.00% | 0.0% |
| Q4 2016 | $409,000 | +43.5% | 25,650 | +28.7% | 0.00% | 0.0% |
| Q4 2014 | $285,000 | +32.6% | 19,932 | -3.9% | 0.00% | – |
| Q3 2014 | $215,000 | -49.3% | 20,747 | -20.8% | 0.00% | -100.0% |
| Q2 2014 | $424,000 | +1.0% | 26,196 | +1.3% | 0.00% | 0.0% |
| Q1 2014 | $420,000 | +81.0% | 25,868 | +38.2% | 0.00% | 0.0% |
| Q4 2013 | $232,000 | +51.6% | 18,719 | +34.4% | 0.00% | – |
| Q3 2013 | $153,000 | +37.8% | 13,930 | +1.8% | 0.00% | – |
| Q2 2013 | $111,000 | – | 13,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |